1 |
Rispoli DZ, Camargo PM, Pires JL Jr, Fonseca VR, Mandelli KK, Pereira MAC. Benign masseter muscle hypertrophy. Braz J Otorhinolaryngol 2008;74:790-793.
DOI
|
2 |
Ham JW. Masseter muscle reduction procedure with radiofrequency coagulation. J Oral Maxillofac Surg 2009;67:457-463.
DOI
|
3 |
Hwang K, Kim YJ, Park H, Chung IH. Selective neurectomy of the masseteric nerve in masseter hypertrophy. J Craniofac Surg 2004;15:780-784.
DOI
|
4 |
International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia 2020;40:129-221.
DOI
|
5 |
Botelho LM, Morales-Quezada L, Rozisky JR, et al. A framework for understanding the relationship between descending pain modulation, motor corticospinal, and neuroplasticity regulation systems in chronic myofascial pain. Front Hum Neurosci 2016;10:308.
|
6 |
Gerwin RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep 2001;5:412-420.
DOI
|
7 |
Benoliel R, Svensson P, Heir GM, et al. Persistent orofacial muscle pain. Oral Dis 2011;17 Suppl 1:23-41.
DOI
|
8 |
Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med 2008;359:2693-2705.
DOI
|
9 |
Simons DG, Travell JG, Simons LS. Travell & Simons' myofascial pain and dysfunction. Vol. 1. Upper half of body. Baltimore: Williams & Wilkins; 1999. pp. 1038.
|
10 |
Masuda M, Iida T, Exposto FG, et al. Referred pain and sensations evoked by standardized palpation of the masseter muscle in healthy participants. J Oral Facial Pain Headache 2018;32:159-166.
DOI
|
11 |
Okeson JP. Management of temporomandibular disorders and occlusion. 7th ed. St. Louis: Elsevier/Mosby; 2013.
|
12 |
Rocabado M, Iglarsh Z. Physical modalities and manual techniques used in the treatment of maxillofacial pain. In: Rocabado M, Iglarsh Z, eds. Musculoskeletal approach to maxillofacial pain. Philadelphia: Lippincott; 1991. pp. 187-192.
|
13 |
Haviv Y, Zini A, Sharav Y, Almoznino G, Benoliel R. Nortriptyline compared to amitriptyline for the treatment of persistent masticatory myofascial pain. J Oral Facial Pain Headache 2019;33:7-13.
DOI
|
14 |
Huang JL, Chen G, Chen XD, Zhou BR, Luo D. A comparative study of the efficacy and safety of radiofrequency ablation and botulinum toxin A in treating masseteric hypertrophy. Exp Ther Med 2014;7:1203-1208.
DOI
|
15 |
Kwon J, Lee M, Lee K, Choi M. Masseter muscle reduction using radiofrequency rhizotomy. J Korean Soc Aesthet Plast Surg 2008;14:43-48.
|
16 |
Gurney CE. Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 1947;73:137-139.
DOI
|
17 |
Beckers HL. Masseteric muscle hypertrophy and its intraoral surgical correction. J Maxillofac Surg 1977;5:28-35.
DOI
|
18 |
Park Y, Jo Y, Bang S, et al. Radiofrequency volumetric reduction for masseteric hypertrophy. Aesthetic Plast Surg 2007;31:42-52.
DOI
|